PYC Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month -0.01 -20.00
Volume 213208 1 Year 0.02 100.00
52 Week High 0.05
52 Week Low 0.02
PYC Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
NWE 0.01 0.00%
NWE 0.01 0.00%
NWE 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BLY 0.03 -25.00%
LYC 0.18 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
ADX 0.02 100.00%
ADX 0.02 100.00%
ADX 0.02 100.00%
HHM 0.02 100.00%
AOK 0.02 100.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
RRP 0.08 -90.59%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
QSS 0.01 -50.00%
GDY 0.01 -50.00%
AGJ 0.03 -40.00%
AGJ 0.03 -40.00%
More..

Phylogica Ltd (ASX: PYC)

PYC Technical Analysis 2
As on 20th Sep 2017 PYC Share Price closed @ 0.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
PYC Target for September
1st Target up-side 0.06
2nd Target up-side 0.06
3rd Target up-side 0.06
1st Target down-side 0.04
2nd Target down-side 0.04
3rd Target down-side 0.04
PYC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.phylogica.com.au
PYC Address
PYC
Telethon Institute for Child Health Research
100 Roberts Road
Subiaco, WA 6008
Australia
Phone: 61 8 9489 7777
Fax: 61 8 9489 7700
PYC Latest News
Interactive Technical Analysis Chart Phylogica Ltd ( PYC ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Phylogica Ltd
PYC Business Profile
Phylogica Limited provides drug discovery services utilizing Phylomer peptide libraries and screening methodologies to identify peptide drug candidates for its pharmaceutical and biotechnology partners in Australia. Its proprietary Phylomer libraries contain various peptides that represent a source of biologically active drug leads for a range of intracellular and extracellular disease targets; and Phylomer peptides are bioactive fragments of naturally occurring proteins, which are encoded in the genomes of evolutionary diverse microbes. The company’s Phylomer peptides include protein interactions that promote various diseases, such as infectious diseases, cancer, autoimmunity, and heart diseases. It has approximately 16 patent families comprising multiple granted/allowed patents in the United States and Australia, which cover methods of making the Phylomer libraries; methods of screening them and composition-of-matter claims for Phylomer libraries; and individual Phylomer peptides discovered for therapeutic and diagnostic applications. The company is based in Subiaco, Australia.